D. Allred

发表

Survival of patients with metastatic breast carcinoma

Jenny C. Chang, R. Elledge, G. Clark, 2003, Cancer.

Estradiol regulates different genes in human breast tumor xenografts compared with the identical cells in culture.

K. Horwitz, D. Allred, C. Sartorius, 2006, Endocrinology.

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

Syed Mohsin, Susan G Hilsenbeck, S. Hilsenbeck, 2003, The Lancet.

A Roundtable Discussion of Aromatase Inhibitors as Therapy for Breast Cancer

A. Howell, M. Dowsett, W. Gradishar, 2003, The breast journal.

Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomas.

D. Allred, J. E. Johnson, S. Olson, 2009, Archives of pathology & laboratory medicine.

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand‐binding assay compared with ER, PgR and pS2, by immuno‐histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study

S. Martino, R. Elledge, G. Clark, 2000, International journal of cancer.

Progesterone-action in the murine uterus and mammary gland requires steroid receptor coactivator 2: relevance to the human.

F. DeMayo, J. Lydon, P. Amato, 2007, Frontiers in bioscience : a journal and virtual library.

Steroid receptor coactivator 2 is essential for progesterone-dependent uterine function and mammary morphogenesis: Insights from the mouse—implications for the human

F. DeMayo, J. Lydon, P. Amato, 2006, The Journal of Steroid Biochemistry and Molecular Biology.

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer

P. Brown, D. Medina, C. Allred, 2004, Breast Cancer Research.

Lobular neoplasia on core‐needle biopsy—Clinical significance

R. Elledge, G. Arpino, S. Mohsin, 2004, Cancer.

Biological and genetic properties of the p53 null preneoplastic mammary epithelium

F. Kittrell, R. Ullrich, D. Medina, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline‐based neoadjuvant chemotherapy in patients with breast carcinoma

Henry M Kuerer, G. Hortobagyi, H. Kuerer, 2002, Cancer.

HER-2 Amplification, HER-1 Expression, and Tamoxifen Response in Estrogen Receptor-Positive Metastatic Breast Cancer

C. Osborne, S. Martino, R. Elledge, 2004, Clinical Cancer Research.

Steroid receptor coactivator 2 is required for female fertility and mammary morphogenesis: insights from the mouse, relevance to the human

F. DeMayo, J. Lydon, P. Amato, 2007, Nuclear receptor signaling.

Caution concerning micrometastatic breast carcinoma in sentinel lymph nodes

R. Elledge, D. Allred, D. C. Allred, 1999, Cancer.

Mammary Tumorigenesis and Metastasis Caused by Overexpression of Insulin Receptor Substrate 1 (IRS-1) or IRS-2

Adrian V. Lee, X. Cui, S. Mohsin, 2006, Molecular and Cellular Biology.

Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland.

C. Kahn, S. Oesterreich, J. Rosen, 2003, Endocrinology.

Molecular Heterogeneity of Inflammatory Breast Cancer: A Hyperproliferative Phenotype

S. Hilsenbeck, P. O’Connell, Jenny C. Chang, 2006, Clinical Cancer Research.

Histological and biological evolution of human premalignant breast disease.

S. Fuqua, D. Allred, D. Allred, 2001, Endocrine-related cancer.

Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer

S. Hilsenbeck, D. Medina, S. Mohsin, 2005, Breast Cancer Research.

Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models

H. Varmus, K. Podsypanina, M. Lewis, 2006, Proceedings of the National Academy of Sciences.

Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma

T. Powles, M. Dowsett, S. Ashley, 2000, Cancer.

Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα+ tumorigenesis

R. Schreiber, J. White, W. Vermi, 2013, Cell Death and Differentiation.

Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIα for anthracycline chemotherapy in locally advanced breast cancer

R. Elledge, H. Weiss, G. Arpino, 2005, Breast Cancer Research and Treatment.

Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.

K. Horwitz, D. Allred, J. Harrell, 2006, Cancer research.

Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia

S. Hilsenbeck, M. Lewis, Xiaomei Zhang, 2007, Development.

Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary results.

S. Hilsenbeck, Jenny C. Chang, R. Elledge, 2003, Clinical breast cancer.

Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinoma.

A. Nicholson, D. Henderson, D. Zander, 2006, Archives of pathology & laboratory medicine.

Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers

S. Hilsenbeck, Jenny C. Chang, R. Elledge, 2005, Breast Cancer Research and Treatment.

Evolution of PBL from normal epithelium to DCIS

D. Allred, S. Mohsin, 2004 .